![PDF) Deflazacort: Therapeutic index, relative potency and equivalent doses versus other corticosteroids PDF) Deflazacort: Therapeutic index, relative potency and equivalent doses versus other corticosteroids](https://www.researchgate.net/publication/312263309/figure/tbl1/AS:669353192202271@1536597645931/Relative-potencies-of-main-corticosteroids-modified-from-1_Q320.jpg)
PDF) Deflazacort: Therapeutic index, relative potency and equivalent doses versus other corticosteroids
![Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes | Critical Care | Full Text Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-020-03400-9/MediaObjects/13054_2020_3400_Fig2_HTML.png)
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes | Critical Care | Full Text
![Steven Chen 陳持威 on Twitter: "80 mg! How did I get there? With my favorite mnemonic (credit to Dr. Anita Vanka)! H+P to the MD, 20, 5, 4, 1 20 of hydrocortisone Steven Chen 陳持威 on Twitter: "80 mg! How did I get there? With my favorite mnemonic (credit to Dr. Anita Vanka)! H+P to the MD, 20, 5, 4, 1 20 of hydrocortisone](https://pbs.twimg.com/media/EsOtQdDUYAEx9oR.jpg)
Steven Chen 陳持威 on Twitter: "80 mg! How did I get there? With my favorite mnemonic (credit to Dr. Anita Vanka)! H+P to the MD, 20, 5, 4, 1 20 of hydrocortisone
![USPharmacist.com > Management of Cushing's Syndrome | Cushings syndrome, Cushing's syndrome, Syndrome USPharmacist.com > Management of Cushing's Syndrome | Cushings syndrome, Cushing's syndrome, Syndrome](https://i.pinimg.com/474x/5f/65/ac/5f65ace0fc5cc5e1837fda82677aeeec--cushings-syndrome-thyroid.jpg)
USPharmacist.com > Management of Cushing's Syndrome | Cushings syndrome, Cushing's syndrome, Syndrome
![The impact of pharmacy mediated conversion from intravenous to oral corticosteroids in patients with an exacerbation of chronic obstructive pulmonary disease The impact of pharmacy mediated conversion from intravenous to oral corticosteroids in patients with an exacerbation of chronic obstructive pulmonary disease](https://oatext.com/img/JTS-3-189.jpg)
The impact of pharmacy mediated conversion from intravenous to oral corticosteroids in patients with an exacerbation of chronic obstructive pulmonary disease
![Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia | Journal of Perinatology Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia | Journal of Perinatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41372-021-01083-w/MediaObjects/41372_2021_1083_Fig4_HTML.png)
Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia | Journal of Perinatology
![A Comparison of Inhaled Fluticasone and Oral Prednisone for Children with Severe Acute Asthma | NEJM A Comparison of Inhaled Fluticasone and Oral Prednisone for Children with Severe Acute Asthma | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2000/nejm_2000.343.issue-10/nejm200009073431003/production/images/img_medium/nejm200009073431003_t2.jpeg)
A Comparison of Inhaled Fluticasone and Oral Prednisone for Children with Severe Acute Asthma | NEJM
![Table 4 from Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids | Semantic Scholar Table 4 from Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6cf961f363c5edad35101cff071e32e7dd5ef12e/7-Table4-1.png)